GNOM holdings
All 52 positions of Global X Genomics & Biotechnology ETF.
Positions
52
Top 10 weight
55.9%
Effective holdings
22.2
1 / sum of squared weights
In stocks
98.9%
In bonds
0.0%
Outside the US
2.5%
Asset mix
Sectors
96% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | MRNAModerna, Inc. Common Stock | Equity | 11.33% | $12M | 53,957 | US |
| 2 | TWSTTwist Bioscience Corporation Common Stock | Equity | 6.87% | $7.4M | 46,055 | US |
| 3 | TXG10x Genomics, Inc. Class A Common Stock | Equity | 6.67% | $7.1M | 88,623 | US |
| 4 | ILMNIllumina Inc | Equity | 5.97% | $6.4M | 22,989 | US |
| 5 | NTRANatera, Inc. Common Stock | Equity | 5.40% | $5.8M | 14,432 | US |
| 6 | GHGuardant Health, Inc. Common Stock | Equity | 5.24% | $5.6M | 33,493 | US |
| 7 | GENSCRIPT BIOTECH CORP | Equity | 4.49% | $4.8M | 889,618 | |
| 8 | TECHBio-Techne Corp. | Equity | 3.46% | $3.7M | 51,203 | US |
| 9 | VRTXVertex Pharmaceuticals Inc | Equity | 3.27% | $3.5M | 6,858 | US |
| 10 | QGENQIAGEN N.V. | Equity | 3.18% | $3.4M | 75,059 | |
| 11 | BMRNBioMarin Pharmaceuticals Inc | Equity | 2.83% | $3.0M | 55,397 | US |
| 12 | CRSPCRISPR Therapeutics AG | Equity | 2.65% | $2.8M | 53,173 | |
| 13 | CAICaris Life Sciences, Inc. Common Stock | Equity | 2.62% | $2.8M | 94,322 | US |
| 14 | VCYTVeracyte, Inc. | Equity | 2.58% | $2.8M | 60,992 | US |
| 15 | BNTXBioNTech SE American Depositary Share | Equity | 2.50% | $2.7M | 27,632 | DE |
| 16 | ARWRArrowhead Research Corporation | Equity | 2.38% | $2.5M | 40,574 | US |
| 17 | PRAXPraxis Precision Medicines, Inc. Common Stock | Equity | 2.16% | $2.3M | 8,897 | US |
| 18 | CDNACareDx, Inc. | Equity | 2.13% | $2.3M | 35,828 | US |
| 19 | LEGNLegend Biotech Corporation American Depositary Shares | Equity | 2.01% | $2.2M | 115,681 | |
| 20 | LLYEli Lilly & Co. | Equity | 1.78% | $1.9M | 1,614 | US |
| 21 | BEAMBeam Therapeutics Inc. Common Stock | Equity | 1.75% | $1.9M | 72,811 | US |
| 22 | GILDGilead Sciences Inc | Equity | 1.59% | $1.7M | 11,283 | US |
| 23 | BLLNBillionToOne, Inc. Class A Common Stock | Equity | 1.42% | $1.5M | 15,483 | US |
| 24 | SRPTSarepta Therapeutics,, Inc. Common Stock | Equity | 1.30% | $1.4M | 78,138 | US |
| 25 | WGSGeneDx Holdings Corp. Class A Common Stock | Equity | 1.27% | $1.4M | 20,164 | US |
| 26 | ASTRAZENECA PLC | Cash | 1.13% | $1.2M | 7,647 | GB |
| 27 | NTLAIntellia Therapeutics, Inc | Equity | 1.07% | $1.1M | 87,900 | US |
| 28 | RAREUltragenyx Pharmaceutical Inc. | Equity | 1.05% | $1.1M | 72,977 | US |
| 29 | DHRDanaher Corporation | Equity | 1.02% | $1.1M | 4,979 | US |
| 30 | VIRVir Biotechnology, Inc. Common Stock | Equity | 0.99% | $1.1M | 90,343 | US |
| 31 | QUREuniQure N.V. | Equity | 0.92% | $981K | 43,409 | |
| 32 | BMYBristol-Myers Squibb Co. | Equity | 0.87% | $927K | 15,687 | US |
| 33 | STOKStoke Therapeutics, Inc. Common Stock | Equity | 0.84% | $903K | 36,512 | US |
| 34 | PSNLPersonalis, Inc. Common Stock | Equity | 0.80% | $861K | 53,799 | US |
| 35 | MRVIMaravai LifeSciences Holdings, Inc. Class A Common Stock | Equity | 0.57% | $612K | 82,316 | US |
| 36 | PACBPacific Biosciences of California, Inc. | Equity | 0.46% | $494K | 211,942 | US |
| 37 | WVEWave Life Sciences Ltd. Ordinary Shares | Equity | 0.39% | $420K | 121,472 | |
| 38 | AAgilent Technologies Inc. | Equity | 0.35% | $371K | 2,174 | US |
| 39 | FLGTFulgent Genetics, Inc. Common Stock | Equity | 0.31% | $336K | 15,451 | US |
| 40 | BRKRBruker Corporation | Equity | 0.31% | $333K | 5,667 | US |
| 41 | PRMEPrime Medicine, Inc. Common Stock | Equity | 0.28% | $297K | 74,338 | US |
| 42 | MYGNMyriad Genetics Inc | Equity | 0.28% | $295K | 68,533 | US |
| 43 | RGNXREGENXBIO Inc. | Equity | 0.27% | $292K | 36,231 | US |
| 44 | MLABMesa Laboratories Inc | Equity | 0.26% | $283K | 2,216 | US |
| 45 | DGXQuest Diagnostics Inc. | Equity | 0.24% | $255K | 1,102 | US |
| 46 | BNTCBenitec Biopharma Inc. Common Stock | Equity | 0.21% | $228K | 25,680 | US |
| 47 | EDITEditas Medicine, Inc. Common Stock | Equity | 0.21% | $222K | 76,597 | US |
| 48 | RCKTRocket Pharmaceuticals, Inc. Common Stock | Equity | 0.19% | $206K | 80,642 | US |
| 49 | LABStandard BioTools Inc. Common Stock | Equity | 0.15% | $165K | 239,024 | US |
| 50 | CRBUCaribou Biosciences, Inc. Common Stock | Equity | 0.04% | $44K | 95,422 | US |
| 51 | OTHER PAYABLE & RECEIVABLES | Equity | 0.01% | $7K | 7,313 | |
| 52 | CASH | Cash | -0.05% | −$49K | -49,091 |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Decrease | MRNAMODERNA, INC. | 7.86% | 3.28% | −53.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | RNAMAvidity Biosciences Inc | 3.75% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | ALNYALNYLAM PHARMACEUTICALS, INC. | 2.51% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | PRAXPraxis Precision Medicines Inc | 6.23% | 4.01% | −39.0% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | CAICARIS LIFE SCIENCES, INC. | — | 2.03% | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | BillionToOne Inc | — | 1.97% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | LEGNLegend Biotech Corp | 2.14% | 4.05% | +30.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TWSTTwist Bioscience Corp | 2.30% | 3.97% | +19.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | ARWRARROWHEAD PHARMACEUTICALS, INC. | 5.69% | 4.07% | −42.7% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | BMYBRISTOL-MYERS SQUIBB COMPANY | 2.65% | 1.16% | −53.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | VCYTVeracyte Inc | 2.39% | 3.64% | +18.5% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | DHRDANAHER CORPORATION | — | 1.17% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | STOKStoke Therapeutics Inc | 0.31% | 1.45% | +437.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TXG10X Genomics Inc | 2.16% | 3.23% | +20.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | GHGUARDANT HEALTH, INC. | 4.71% | 5.59% | −15.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | BEAMBeam Therapeutics Inc | 2.21% | 3.09% | +19.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | QUREUniqure NV | 0.72% | 1.59% | +19.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | Genscript Biotech Corp | 1.45% | 2.00% | +18.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | SRPTSAREPTA THERAPEUTICS, INC. | 1.31% | 1.80% | +26.8% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | RAREUltragenyx Pharmaceutical Inc | 1.78% | 2.25% | +22.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | WVEWAVE Life Sciences Ltd | 1.50% | 1.03% | +43.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | ASTRAZENECA PLC | 2.28% | 1.83% | −10.9% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | BRKRBRUKER CORPORATION | — | 0.43% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | VIRVir Biotechnology Inc | 0.70% | 1.11% | +49.7% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | NTLAINTELLIA THERAPEUTICS, INC. | 1.19% | 1.59% | +29.7% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | BNTCBenitec Biopharma Inc | — | 0.38% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | PSNLPersonalis Inc | 0.41% | 0.79% | +51.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | WGSGeneDx Holdings Corp | 1.72% | 1.35% | +18.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CRSPCRISPR Therapeutics AG | 3.48% | 3.85% | +16.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | ILMNILLUMINA, INC. | 5.13% | 4.82% | −23.5% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | DGXQUEST DIAGNOSTICS INCORPORATED | — | 0.28% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | ARCTArcturus Therapeutics Holdings Inc | 0.24% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | SANASana Biotechnology Inc | 0.21% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | SGMOQSANGAMO THERAPEUTICS, INC. | 0.20% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | MRVIMaravai LifeSciences Holdings Inc | 0.32% | 0.51% | +16.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | FLGTFULGENT GENETICS, INC. | 0.26% | 0.36% | +16.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | QGENQiagen N.V. | 3.63% | 3.54% | +30.6% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | LABSTANDARD BIOTOOLS INC. | 0.26% | 0.35% | +32.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | RNAAtrium Therapeutics Inc | 0.08% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | MLABMESA LABORATORIES, INC. | 0.34% | 0.29% | −20.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | RCKTROCKET PHARMACEUTICALS, INC. | 0.36% | 0.32% | +42.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TECHBIO-TECHNE CORPORATION | 3.45% | 3.41% | +11.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | RGNXRegenxbio Inc | 0.35% | 0.33% | +17.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 0.38% | 0.40% | +17.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | PRMEPrime Medicine, Inc | 0.36% | 0.34% | +20.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | AAGILENT TECHNOLOGIES, INC. | 0.38% | 0.38% | −13.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | MYGNMYRIAD GENETICS, INC. | 0.35% | 0.35% | +15.5% | Feb 28, 2026 → May 31, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.